NCT01877642View on ClinicalTrials.gov

ADASUVE-Lorazepam Drug-Drug Interaction

PHASE4CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2013

Study Completion Date

July 31, 2013

Conditions
Healthy Volunteers
Interventions
DRUG

Lorazepam 1 mg IM

Lorazepam 1 mg intramuscular

DRUG

Inhaled loxapine 10 mg

Inhaled Staccato loxapine 10 mg

DRUG

Inhaled Placebo

Inhaler with no drug in it to mimic the ADASUVE inhaler

DRUG

Placebo IM

intramuscular placebo to mimic lorazepam 1 mg IM

Trial Locations (1)

47710

Covance-Evansville, Evansville

Sponsors
All Listed Sponsors
lead

Alexza Pharmaceuticals, Inc.

INDUSTRY